A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Active, not recruiting · NCT02057133 · Registry updated 2026-01-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 1 | 2026-01-26 | NCT02057133 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University College of Phys & Surgeons | New York | United States | 1 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Highlands Oncology Group - Duplicate 2 | Rogers | United States | 2 |
| Mayo Clinic | Rochester | United States | 5 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Peggy and Charles Stephenson Oklahoma Cancer Center | Nashville | United States | 1 |
| Providence Cancer Center Oncology Hematology Care | Portland | United States | 2 |
| South Texas Accelerated Research Therapeutics (START) | San Antonio | United States | 4 |
| Tennessee Oncology PLLC | Nashville | United States | 14 |
| Univ of Pittsburgh Cancer Inst. (UPCI) | Pittsburgh | United States | 2 |
| University of California - San Diego | La Jolla | United States | 2 |
| University of North Carolina At Chapel Hill | Chapel Hill | United States | 50 |
| Vanderbilt University Medical Center | Nashville | United States | 2 |